<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kibaly C</submitter><funding>NIDA NIH HHS</funding><funding>National Institutes of Health</funding><pagination>153-168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5392433</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>119</volume><pubmed_abstract>The development of tolerance to morphine, one of the most potent analgesics, in the management of chronic pain is a significant clinical problem and its mechanisms are poorly understood. Morphine exerts its pharmacological effects via the μ-opioid receptor (MOR). Tolerance is highly connected to G-protein-coupled receptors (GPCR) phosphorylation and desensitization increase. Because morphine desensitization previously has been shown to be MOR phosphorylation- and ß-arrestin2-independent (in contrast to agonists such as fentanyl), we examined the contribution of phosphorylation of the entire C-terminus to the development of antinociceptive tolerance to the partial (morphine) and full (fentanyl) MOR agonists in vivo. In MOR knockout (MORKO) mice, we delivered via lentivirus the genes encodin</pubmed_abstract><journal>Pharmacological research</journal><pubmed_title>Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.</pubmed_title><pmcid>PMC5392433</pmcid><funding_grant_id>DA031442</funding_grant_id><funding_grant_id>P50 DA011806</funding_grant_id><funding_grant_id>R01 DA031442</funding_grant_id><funding_grant_id>DA011806</funding_grant_id><pubmed_authors>Kibaly C</pubmed_authors><pubmed_authors>Loh HH</pubmed_authors><pubmed_authors>Lin HY</pubmed_authors><pubmed_authors>Law PY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.</name><description>The development of tolerance to morphine, one of the most potent analgesics, in the management of chronic pain is a significant clinical problem and its mechanisms are poorly understood. Morphine exerts its pharmacological effects via the μ-opioid receptor (MOR). Tolerance is highly connected to G-protein-coupled receptors (GPCR) phosphorylation and desensitization increase. Because morphine desensitization previously has been shown to be MOR phosphorylation- and ß-arrestin2-independent (in contrast to agonists such as fentanyl), we examined the contribution of phosphorylation of the entire C-terminus to the development of antinociceptive tolerance to the partial (morphine) and full (fentanyl) MOR agonists in vivo. In MOR knockout (MORKO) mice, we delivered via lentivirus the genes encodin</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2025-04-04T02:12:05.683Z</modification><creation>2019-03-26T23:33:50Z</creation></dates><accession>S-EPMC5392433</accession><cross_references><pubmed>28179123</pubmed><doi>10.1016/j.phrs.2017.01.033</doi></cross_references></HashMap>